Wiesel Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 38.98%
- Profit Growth -6.54%
- Ebitda -146.64%
- Net Worth 80.95%
- Total Assets 9.50%
About Wiesel Pharmaceutical
Wiesel Pharmaceutical Private Limited (WPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 23 April 2018 (Six years and nine months 24 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Shailesh Chaudhary and Nitin Chaudhary serve as directors at the Company.
Company Details
-
Location
Lucknow, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24304UP2018PTC103509
-
Company No.
103509
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Apr 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Wiesel Pharmaceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shailesh Chaudhary
|
Director | 05-Feb-2019 | Current |
|
Nitin Chaudhary
|
Director | 23-Apr-2018 | Current |
Financial Performance of Wiesel Pharmaceutical.
Wiesel Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 38.98% increase. The company also saw a slight decrease in profitability, with a 6.54% decrease in profit. The company's net worth Soared by an impressive increase of 80.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wiesel Pharmaceutical?
In 2021, Wiesel Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Varsha Infratech Private LimitedShailesh Chaudhary is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wiesel Pharmaceutical?
Unlock and access historical data on people associated with Wiesel Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wiesel Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wiesel Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
